Our top pick for
Landec Corporation is a packaged foods business based in the US. Landec Corporation shares (LNDC) are listed on the NASDAQ and all prices are listed in US Dollars. Landec Corporation employs 796 staff and has a trailing 12-month revenue of around USD$587.3 million.
|Latest market close||USD$10.94|
|52-week range||USD$7.48 - USD$11.89|
|50-day moving average||USD$10.5186|
|200-day moving average||USD$9.9243|
|Wall St. target price||USD$14|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.159|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||1.86%|
|1 month (2020-12-16)||-0.45%|
|3 months (2020-10-15)||5.60%|
|6 months (2020-07-15)||23.06%|
|1 year (2020-01-15)||-1.35%|
|2 years (2019-01-15)||-6.66%|
|3 years (2018-01-12)||12.8|
|5 years (2016-01-15)||0.64%|
Valuing Landec Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Landec Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Landec Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 22.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Landec Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Landec Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$10 million.
The EBITDA is a measure of a Landec Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$587.3 million|
|Gross profit TTM||USD$72 million|
|Return on assets TTM||-0.94%|
|Return on equity TTM||-18.27%|
|Market capitalisation||USD$291.1 million|
TTM: trailing 12 months
There are currently 1.1 million Landec Corporation shares held short by investors – that's known as Landec Corporation's "short interest". This figure is 0.6% down from 1.1 million last month.
There are a few different ways that this level of interest in shorting Landec Corporation shares can be evaluated.
Landec Corporation's "short interest ratio" (SIR) is the quantity of Landec Corporation shares currently shorted divided by the average quantity of Landec Corporation shares traded daily (recently around 131093.85150812). Landec Corporation's SIR currently stands at 8.62. In other words for every 100,000 Landec Corporation shares traded daily on the market, roughly 8620 shares are currently held short.
However Landec Corporation's short interest can also be evaluated against the total number of Landec Corporation shares, or, against the total number of tradable Landec Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Landec Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Landec Corporation shares in existence, roughly 40 shares are currently held short) or 0.0433% of the tradable shares (for every 100,000 tradable Landec Corporation shares, roughly 43 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Landec Corporation.
Find out more about how you can short Landec Corporation stock.
We're not expecting Landec Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Landec Corporation's shares have ranged in value from as little as $7.48 up to $11.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Landec Corporation's is 1.0499. This would suggest that Landec Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets. It operates through Curation Foods and Lifecore segments. The Curation Foods segment engages in processing, marketing, and selling of vegetable-based salads, and fresh-cut and whole vegetable products primarily under the Eat Smart brand, O branded olive oils and wine vinegars, and Yucatan and Cabo Fresh guacamole and avocado food products, as well as various private labels. It serves retail grocery chains, club stores, and food service operators. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology transfer, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. It sells its products directly to partners in the medical device and pharmaceutical markets. The company was founded in 1986 and is headquartered in Santa Clara, California.
Everything we know about the Home Point Capital Inc IPO, plus information on how to buy in.
Everything we know about the ALFI INC IPO, plus information on how to buy in.
Steps to owning and managing CDAY, with 24-hour and historical pricing before you buy.
Steps to owning and managing CPF, with 24-hour and historical pricing before you buy.
Steps to owning and managing CFFI, with 24-hour and historical pricing before you buy.
Steps to owning and managing BPY, with 24-hour and historical pricing before you buy.
Steps to owning and managing BANF, with 24-hour and historical pricing before you buy.
Steps to owning and managing AVDL, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEAM, with 24-hour and historical pricing before you buy.
Steps to owning and managing AUDC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.